Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Treena Orchard, Associate Professor, School of Health Studies, Western University

The GLP-1 disclosure dilemma: Should you tell a date you’re using Ozempic for weight loss?

As a Gen Xer who lived through the “heroin chic” years, when skeletal models were celebrated for jutting bones and sallow skin, the recent popularity of the #Y2KSkinny trend fills me with dread.

This return of size 00 bodies is fuelled by the fashion industry, looksmaxxing and SkinnyTok influencers who promote thinness as wellness. But increasingly, the biggest driver is a drug class: GLP-1s.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.